Cycle 3: PCORI Research Awards

Sponsor: Patient-Centered Outcomes Research Institute (PCORI)
LOI Due Date: October 4, 2022 at 5pm ET
Application Due Date: January 10, 2023 at 5pm ET

Awards:
Phased Large Awards for Comparative Effectiveness Research: $22 million (Feasibility phase: $2 million; Full-scale study phase: $20 million)
Comparative Effectiveness of Multimodal Interventions to Prevent Osteoporotic Fractures: Up to $10 million
Comparative Effectiveness of Novel Pharmacologic and Evidence-Based Nonpharmacologic Treatments for Migraine Prevention: Up to $10 million
Healthy Aging: Optimizing Physical and Mental Functioning Across the Aging Continuum: Up to $5 million
Broad PCORI Funding Announcements: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Healthcare Systems: up to $3 million (Small) – up to $5 million (Large) — Communication & Dissemination Research: up to $2 million.
Improving Methods for Conducting Patient-Centered Outcomes Research: “In this PCORI Funding Announcement (PFA), we seek to fund projects to address methodological gaps relevant to conducting patient-centered outcomes research (PCOR)/comparative effectiveness research (CER). The improvement of methods for PCOR/CER will benefit all stakeholders, including researchers planning investigations; policy makers assessing the value of healthcare interventions; and patients, clinicians, and caregivers facing healthcare decisions. Funds available up to $12 million.”

You can register here Virtual Applicant Town Halls for these Funding Announcements